Related Experiment Video
Updated: Mar 13, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Direct Regulation of Alternative Splicing by SMAD3 through PCBP1 Is Essential to the Tumor-Promoting Role of TGF-β
Veenu Tripathi1, Katherine M Sixt1, Shaojian Gao2
1Laboratory of Cellular and Molecular Biology, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.
Abstract:
In advanced stages of cancers, TGF-β promotes tumor progression in conjunction with inputs from receptor tyrosine kinase pathways. However, mechanisms that underpin the signaling cooperation and convert TGF-β from a potent growth inhibitor to a tumor promoter are not fully understood. We report here that TGF-β directly regulates alternative splicing of cancer stem cell marker CD44 through a phosphorylated T179 of SMAD3-mediated interaction with RNA-binding protein PCBP1. We show that TGF-β and EGF respectively induce SMAD3 and PCBP1 to colocalize in SC35-positive nuclear speckles, and the two proteins interact in the variable exon region of CD44 pre-mRNA to inhibit spliceosome assembly in favor of expressing the mesenchymal isoform CD44s over the epithelial isoform CD44E. We further show that the SMAD3-mediated alternative splicing is essential to the tumor-promoting role of TGF-β and has a global influence on protein products of genes instrumental to epithelial-to-mesenchymal transition and metastasis.
Insights
Transforming growth factor-beta (TGF-β) switches from inhibiting to promoting cancer by altering CD44 splicing via SMAD3 and PCBP1 interaction. This mechanism is crucial for tumor progression and metastasis.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Signaling
Background:
- Transforming growth factor-beta (TGF-β) paradoxically promotes tumor progression in advanced cancers, despite its inhibitory role in early stages.
- The mechanisms by which TGF-β cooperates with receptor tyrosine kinase pathways to drive tumor growth remain incompletely understood.
Purpose of the Study:
- To elucidate the molecular mechanisms underlying TGF-β's switch from a tumor suppressor to a tumor promoter.
- To investigate the role of alternative splicing in TGF-β-mediated cancer progression.
Main Methods:
- Investigated the interaction between SMAD3 and PCBP1 in response to TGF-β and EGF signaling.
- Analyzed the alternative splicing of CD44 pre-mRNA in nuclear speckles.
- Utilized cell-based assays to assess the functional impact of SMAD3-mediated splicing on cancer progression.
Main Results:
- TGF-β directly regulates CD44 alternative splicing through a phosphorylated SMAD3-mediated interaction with PCBP1.
- TGF-β and EGF signaling induce SMAD3 and PCBP1 to colocalize in nuclear speckles, where they interact with CD44 pre-mRNA.
- This interaction inhibits spliceosome assembly, favoring the mesenchymal CD44s isoform over the epithelial CD44E isoform.
- SMAD3-mediated alternative splicing is essential for TGF-β's tumor-promoting functions and influences epithelial-to-mesenchymal transition and metastasis.
Conclusions:
- TGF-β promotes cancer progression by directly altering CD44 alternative splicing via the SMAD3-PCBP1 complex.
- This splicing switch is a critical mechanism for TGF-β to promote epithelial-to-mesenchymal transition and metastasis.
- Targeting this pathway could offer novel therapeutic strategies for advanced cancers.
Related Concept Videos
TGF - β Signaling Pathway
Abnormal Proliferation
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
RNA Splicing
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...
Hedgehog Signaling Pathway

